DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

LinksSchließen

Referenz

Cook D, Meade M, Guyatt G. et al; PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group.
Dalteparin versus unfractionated heparin in critically ill patients.

N Engl J Med 2011;
364 (14) 1305-1314

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: